文献速递肾移植

体重指数、体重调整免疫抑制与肾移植后急性排斥和感染风险:队列研究

Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study.
PubMed 文献 · Nephrol Dial Transplant · 2019-01-01

结果显示BMI 35与急性排斥风险增加相关(aHR=1.29),校正免疫抑制后关联消失(aHR=1.09);致命感染风险校正前无显著关联(aHR=0.91),校正后风险增加(aHR=1.54)。提示肥胖患者免疫抑制相对剂量不足可能部分解释这些关联。

要点

  • 高BMI与肾移植后急性排斥风险增加相关,校正免疫抑制剂量后关联消失。
  • 高BMI与致命感染风险在校正免疫抑制剂量后显著增加。
  • 肥胖患者免疫抑制相对剂量不足可能部分解释不良结局。

核心结论

  • 高BMI与肾移植后急性排斥和致命感染的关联在校正免疫抑制剂量后显著改变,提示肥胖患者相对剂量不足可能部分解释这些关联。

主要发现

  • 与BMI 25 kg/m2相比,BMI 35与急性排斥风险增加相关(aHR=1.29,95%CI 1.12-1.49),校正免疫抑制后关联几乎消失(aHR=1.09,95%CI 0.93-1.29)。
  • BMI 35与致命感染风险无显著关联(aHR=0.91,95%CI 0.66-1.25),但校正免疫抑制后风险增加(aHR=1.54,95%CI 1.03-2.28)。
  • 校正免疫抑制后癌症风险无显著改变;较低BMI与更差结局相关,但校正免疫抑制后无显著改变。

临床怎么用

  • 临床应关注肥胖肾移植受者的免疫抑制剂量,避免因体重调整不足导致急性排斥或感染风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Body mass index (BMI) is associated with patient outcomes after kidney transplantation. We hypothesized that immunosuppression (IS) dosing is a contributing factor. METHODS: Using Australia and New Zealand Dialysis and Transplant registry data, we included all adult kidney-only transplant recipients over 2000-14 treated with prednisolone, mycophenolate and tacrolimus/cyclosporin (n = 7919). The exposure was BMI and the outcomes were time to: (i) acute rejection, (ii) fatal infection, (iii) cancer and (iv) graft; and (v) patient survival. We modelled BMI and IS dosing (in quartiles) as time-varying covariates in extended Cox models. RESULTS: Compared with a BMI of 25 kg/m2, a BMI of 35 was associated with acute rejection after adjusting for demographics and comorbidities [adjusted hazard ratio (aHR) = 1.29, 95% confidence interval (CI) 1.12-1.49]. This association virtually disappeared after correcting for IS (aHR = 1.09, 95% CI 0.93-1.29). A BMI of 35 was non-significantly associated with fewer fatal infections (aHR = 0.91, 95% CI 0.66-1.25), but this reversed after adjusting for IS (aHR = 1.54, 95% CI 1.03-2.28). Results for cancer were not significantly altered after adjusting for IS. Results for lower BMI were similarly not significantly altered though generally associated with worse outcomes. CONCLUSIONS: Our findings show that the associations between high BMI, acute rejection and fatal infection after kidney transplantation were significantly altered after correcting for IS suggesting that relative under-dosing of obese patients may partially explain these associations.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Flabouris K, Chadban S, Ladhani M, et al. Body mass index, weight-adjusted immunosuppression and the risk of acute rejection and infection after kidney transplantation: a cohort study. Nephrol Dial Transplant. 2019. PMID: 31168571. doi:10.1093/ndt/gfz095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。